SRTA SRTA Share-Based Payment - Unrecognized Cost of Nonvested Awards

Share-Based Payment - Unrecognized Cost of Nonvested Awards at other companies

CNB FinancialCCNE

$0—

Helen Of TroyHELE

$20.8M-7.6%

BioventusBVS

$6M+33.4%

Ryan Specialty HoldingsRYAN

$223.55M+9.5%

10x Genomics, Inc.TXG

$19.87-29.9%

GitLabGTLB

$700K-95.8%

Other financials

Income statement

See full

Revenue$67.4M+87.4%

Gross profit$14.1M+100%

Operating income-$3.0M+47.7%

Net income$2.2M+162%

EPS (diluted)$0.03+175%

Balance sheet

See full

Cash & equivalents$59.0M+65.3%

Total debt$4.5M-50.7%

Total equity$285.7M+30.0%

Total assets$327.6M+30.8%

Cash flow

See full

Operating cash flow$3.9M+1,679%

CapEx$5.2M+98.1%

Free cash flow-$1.3M+54.8%

Valuation

See full

Market cap$463.78M+24.0%

Enterprise value$409.26M—

P/E8.9×—

P/S1.8×—

Profitability

See full

Gross margin21.7%+1.3pp

Operating margin-7.8%-2.8pp

Net margin21%+13.6pp

FCF margin-22.4%+1,712pp

Returns & leverage

See full

Return on equity15.6%+10.0pp

Debt / equity0×0.0×

Current ratio5.9×-1.0×

Where this comes from

Reported directly by SRTA in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.

The official record: SRTA’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about SRTA's share-based payment - unrecognized cost of nonvested awards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SRTA's share-based payment - unrecognized cost of nonvested awards?: SRTA (SRTA) reported share-based payment - unrecognized cost of nonvested awards of $3.95 in Q1 2026.
What does share-based payment - unrecognized cost of nonvested awards mean?: This represents the total compensation expense for equity-based awards that has been granted but not yet recognized in the income statement because the vesting conditions have not been met. It serves as a forward-looking indicator of future non-cash compensation expenses. Investors use this to forecast the impact of stock-based compensation on future earnings.